Mini Review-Bladder Cancer (Urological Disorder)

Main Article Content

Pradnya Nilesh Jagtap
Sayali S. Chavan
Nayana Bhikaji Mirke
Pranesh Pandurang Memane

Abstract

Bladder cancer is most common urological disorder. It occurs in any age group. It is common in male rather than female. Bladder cancer have some causal factors. This review focus on bladder cancer causal factor, symptom, Diagnostic test and treatment.

Keywords:
Bladder cancer, urological disorder, diagnostic test.

Article Details

How to Cite
Jagtap, P. N., Chavan, S. S., Mirke, N. B., & Memane, P. P. (2020). Mini Review-Bladder Cancer (Urological Disorder). Asian Journal of Research and Reports in Urology, 3(3), 24-28. Retrieved from https://journalajrru.com/index.php/AJRRU/article/view/30110
Section
Minireview Article

References

Ferlay J, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893-2917.

Available:https://www.mayoclinic.org/diseases-conditions/bladder-cancer/symptoms-auses/syc-20356104 visited on 29/05/2020

Benisoni RCJR, Tomera KM, Kelalis PP. Transitionlal cell carcinomas of the bladder in children and adolescents. J Urol. 1983;130:54-55.

Available:https://www.healthline.com/health/bladder-cancer#symptoms visited on 29/05/2020

Available:https://www.cancer.net/cancer-types/bladder-cancer/risk-factors visited on 31/05/2020

Metts MC, Melts JC, Milito SJ, Thomas CR. Bladder cancer: A review of diagnosis and management. Journal of the National Medical Association; 285-294.

Available:https://www.mayoclinic.org/diseases-conditions/bladder-cancer/diagnosis-treatment/drc-20356109 Visited on 31/05/2020

Vrooman OPJ, Witjes JA. A review- Bladder cancer. Urinary Markers in Bladder Cancer European Urology. 2008;53:909–916.

Available:https://www.mayoclinic.org/diseases-conditions/bladder-cancer/diagnosis-treatment/drc-20356109

Visited on - 31/05/2020

Available:https://www.roswellpark.org/cancer/bladder/diagnosis/bladder-cancer-types

Hall RR. Neo-adjuvant CMV chemotherapy and cystectomy or radiotherapy in muscle invasive bladder cancer: First analysis on MRC/EORTC intercontinental trial. In: Proceedings of the Annual Meeting of the American Society of Clinical Oncology. 1996;15(Abstr 612).

Sternberg CN, Yagoda A, Scher HI, et al. Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urothelium. J Urol. 1985;133:403-407.

Logothetis CJ, Samuels ML, Ogden S, et al. Cyclophosphamide, doxorubicin, and cisplatin chemotherapy for patients with locally advanced urothelial tumors with or without nodal metastases. J Urol. 1985;134:460-464.

Harker WG, Meyers FJ, Freiha FS, et al. Cisplatin, methotrexate, and vinblastine (CMV): An effective chemotherapy regimen for metastatic transitional cell carcinoma of the urinary tract: A Northern California Oncology group study. J Clin Oncol. 1985;3:1463-1470.

Slack NH, Bross IDJ, Prout GR. Five-year follow-up results of a collaborative study of therapies for carcinoma of the bladder. J Surg Oncol. 1977;9:393- 405.

Crawford ED, Das S, Smith JAJR. Preoperative radiation therapy in the treatment of bladder cancer. Urol Clin N Am. 1987;14:781-787.

Blackard CE, Byar DB. VA Cooperative Urology Research Group. Results of a clinical trial of surgery and radiation in stages II and III carcinoma of the bladder. Urol. 1972;108:875-878.

Available:https://contemporaryhealthcenter.com/services/gynecology/urogynecology/cystoscopy/